Titre :
  • Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist.
Auteur : Kramer, J A ; Curran, D. ; Piccart-Gebhart, Martine ; de Haes, J C ; Bruning, Peter ; Klijn, J G ; Bontenbal, M ; van Pottelsberghe, C ; Groenvold, M ; Paridaens, Robert
Informations sur la publication : European journal of cancer, 36, 12, (page 1488-1497)
Statut de publication : Publié, 2000-08
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Antineoplastic Agents -- therapeutic use
Antineoplastic Agents, Phytogenic -- therapeutic use
Bias (Epidemiology)
Breast Neoplasms -- drug therapy
Cross-Over Studies
Disease-Free Survival
Doxorubicin -- therapeutic use
Female
Humans
Paclitaxel -- therapeutic use
Patient Compliance
Prospective Studies
Quality of Life
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase II
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:pii/S0959-8049(00)00134-9
info:pmid/10930796